Watch Oculogica CEO, Dr. Rosina Samadani’s, and founder, Dr. Uzma Samadani’s discussion with the Talk Polymath podcast about the EyeBOX and how eye movement can be used to diagnose and treat concussions.
Rosina Samadani and Dr. Uzma Samadani discuss EyeBOX on Talk Polymath podcast Read More »
Oculogica CEO, Dr. Rosina Samadani, speaks with CEOX for their CEO Interview Series.
CEOX: CEO Interview Series – Rosina Samadani, CEO of Oculogica Read More »
Oculogica receives ground-breaking patent to assess CTE via its eye-tracking technology
Oculogica new patient opens potential CTE test for live subjects Read More »
Oculogica’s patent enables expansion of its eye-tracking based technology to fulfill an unmet need in cannabis impairment detection
Oculogica adds patent for assessment of Impairment due to Cannabis Read More »
Keller Army Hospital at West Point, Children’s Hospital of Philadelphia, University of Wisconsin-Green Bay and AdHawk Microsystems will work with Oculogica to develop the wearable diagnostic
Oculogica receives DoD Grant for Development of Wearable concussion diagnostic Read More »
Oculogica, a medical device company and leader in concussion diagnosis and categorization, announced today the Therapeutic Goods Administration (TGA) of Australia granted approval to its EyeBOX technology. The test is for both pediatrics and adults. The technology is also patent protected in Australia.
Australia Grant Approves First Objective Concussion Diagnostic tool Read More »
Oculogica, the leader in non-invasive assessment of concussion, announces today the granting of U.S. Patent No. 10,863,902 by the U.S. Patent and Trademark Office. This patent protects Oculogica’s method and system for assessing glaucoma in a patient using a noninvasive eye tracking system.
Oculogica Adds to IP Portfolio with Patent for Glaucoma Read More »
Oculogica Founder, Dr. Uzma Samadani and CEO, Dr. Rosina Samadani, join the 11th annual list of women and men from such companies as Netflix, Google, and Patagonia, as well as institutions such as Johns Hopkins University and the ACLU of Massachusetts.
Dr. Uzma Samadani and Rosina Samadani Named to list of Most Creative People in Business Read More »
Last year, the FDA granted authorization for commercial use of the first tool that provides an objective diagnosis of concussions. Called EyeBox, it was developed by sisters Uzma and Rosina Samadani.
Watch our EyeBOX technology featured in Trevor Noah’s and Microsoft President Brad Smith’s discussion with Green Bay Packers President & CEO Mark Murphy.
EyeBOX Featured in Daily Show’s Trevor Noah with Microsoft President Read More »
